Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Operating Leases (2022 - 2023)

Historic Operating Leases for Therapeutics (LENZ) over the last 2 years, with Q3 2023 value amounting to $49.7 million.

  • Therapeutics' Operating Leases rose 188800.0% to $49.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $49.7 million, marking a year-over-year increase of 188800.0%. This contributed to the annual value of $1.7 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Therapeutics reported Operating Leases of $49.7 million as of Q3 2023, which was up 188800.0% from $50.6 million recorded in Q2 2023.
  • In the past 5 years, Therapeutics' Operating Leases ranged from a high of $50.6 million in Q2 2023 and a low of $1.4 million during Q1 2023